Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (South Korea), South Korea, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
75%
Total
Publications
57
Total Open
Publications
43
Total
Citations
468
Open Access
Percentage
75%
Total
Publications
57
Total Open
Publications
43
Total
Citations
468
Breakdown
Publisher Open
33%
Both
40%
Other Platform Open
2%
Closed
25%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 60%
25
Hybrid 26%
11
No Guarantees 14%
6
Other Platform Open
Domain 54%
13
Institution 29%
7
Other Internet 29%
7
Public 21%
5
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 13 |
Europe PMC | Domain | 7 |
Semantic Scholar | Public | 5 |
Yonsei University Medical Library - YUHSpace | Institution | 3 |
Unknown Repository | Other Internet | 3 |
OpenEdition - OpenEdition | Other Internet | 3 |
Universidad de la Rioja - Dialnet | Institution | 2 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 1 |
Universidad de Alicante - RUA, Repositorio Institucional de la Universidad de Alicante | Institution | 1 |
Red Federada de Repositorios Institucionales de Publicaciones CientÃficas - LA Referencia | Institution | 1 |